Researchers Find Protective Effects of Natural Inhibitor

Armen Hareyan's picture

A therapy that improves survival in patients with pulmonary disease may also protect patients who are exposed to cigarette smoke, according to researchers at Ohio State University Medical Center and the University of Colorado.


The findings were recently published in the American Journal of Respiratory and Critical Care Medicine.

"Our lab hypothesized that this potent vasodilator called prostacyclin may help shield patients with chronic obstructive pulmonary disease from pulmonary damage," says Dr. Patrick Nana-Sinkam, co-author of the study and also a pulmonologist and critical care specialist at the Center for Critical Care and Respiratory Medicine at Ohio State

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.